Rationale and design of the Aldose Reductase Inhibition for Stabilization of Exercise Capacity in Heart Failure Trial (ARISE-HF) in patients with high-risk diabetic cardiomyopathy.
- DOI
- 10.1016/j.ahj.2022.11.003
- Published
- 2023 Feb
- Container
- American heart journal
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ahj.2022.11.003,
title = {Rationale and design of the Aldose Reductase Inhibition for Stabilization of Exercise Capacity in Heart Failure Trial (ARISE-HF) in patients with high-risk diabetic cardiomyopathy.},
author = {Januzzi JL Jr and Butler J and Del Prato S and Ezekowitz JA and Ibrahim NE and Lam CSP and Lewis GD and Marwick TH and Rosenstock J and Tang WHW and Zannad F and Lawson F and Perfetti R and Urbinati A},
year = {2023},
journal = {American heart journal},
doi = {10.1016/j.ahj.2022.11.003},
url = {https://doi.org/10.1016/j.ahj.2022.11.003}
}RIS
TY - JOUR TI - Rationale and design of the Aldose Reductase Inhibition for Stabilization of Exercise Capacity in Heart Failure Trial (ARISE-HF) in patients with high-risk diabetic cardiomyopathy. AU - Januzzi JL Jr AU - Butler J AU - Del Prato S AU - Ezekowitz JA AU - Ibrahim NE AU - Lam CSP AU - Lewis GD AU - Marwick TH AU - Rosenstock J AU - Tang WHW AU - Zannad F AU - Lawson F AU - Perfetti R AU - Urbinati A PY - 2023 JO - American heart journal DO - 10.1016/j.ahj.2022.11.003 UR - https://doi.org/10.1016/j.ahj.2022.11.003 ER -
APA
Jr, J. J., J, B., S, D. P., JA, E., NE, I., CSP, L., GD, L., TH, M., J, R., WHW, T., F, Z., F, L., R, P., & A, U. (2023). Rationale and design of the Aldose Reductase Inhibition for Stabilization of Exercise Capacity in Heart Failure Trial (ARISE-HF) in patients with high-risk diabetic cardiomyopathy.. American heart journal. https://doi.org/10.1016/j.ahj.2022.11.003
Source records
- pubmed · retrieved 2026-09-26T22:43:57.090Z